Skip to main content
DYAI
NASDAQ Life Sciences

Dyadic Prices $2.9M Registered Direct Offering with Warrants at $0.795/Share

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.77
Mkt Cap
$28.061M
52W Low
$0.655
52W High
$1.6
52W Position info
18% above low
Off High info
52% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

DYAI sits 18% above its 52-week low of $0.655.

Summary

Dyadic International secured $2.9 million through a registered direct offering and concurrent private placement, pricing shares at $0.795 with warrants exercisable at $0.84. The deal includes standstill and lock-up restrictions, and registration rights for warrant shares.


Key Events · Financing and Capital Events · DYAI

  • Registered Direct Offering Priced

    Dyadic agreed to sell 3,625,000 shares at $0.795 per share, raising approximately $2.9 million in gross proceeds before expenses.

  • Concurrent Warrant Issuance

    Investors received warrants to purchase 3,625,000 shares at $0.84 per share, with a five-year term and a purchase price of $0.005 per warrant.

  • Standstill and Lock-Up Restrictions

    The company agreed to a 90-day standstill on equity issuances and a 90-day lock-up for directors, officers, employees, and 10% shareholders.

  • Registration Rights Agreement

    Dyadic must file a resale registration statement for the warrant shares within 30 days of closing, with penalties for delays.


Analysis · DYAI · Life Sciences

Dyadic International entered into definitive agreements for a $2.9 million registered direct offering and concurrent private placement. The offering includes 3,625,000 shares at $0.795 per share and warrants to purchase an equal number of shares at $0.84 per share. The warrants have a five-year term and were sold at $0.005 each. The company also agreed to a 90-day standstill on equity issuances, a 90-day lock-up for insiders, and registration rights for the warrant shares. This capital raise is critical for Dyadic, which recently disclosed a going concern warning with only $4.8 million in cash. The offering price is slightly above the current market price of $0.7702, indicating some investor demand despite the company's financial distress. The warrants provide additional potential dilution if exercised, but the immediate proceeds extend the company's cash runway.

At the time of this filing, DYAI was trading at $0.77 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $28.1M. The 52-week trading range was $0.65 to $1.60. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DYAI - Latest Insights

DYAI
Aug 13, 2026, 5:25 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $0.7854
Real-time Price: $0.7702 info
Change: -$0.0152 (-2%) info
Market Cap: $28.061M info
DYAI
Aug 13, 2026, 8:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.8492
Real-time Price: $0.7702 info
Change: -$0.079 (-9%) info
Market Cap: $28.061M info
DYAI
Aug 12, 2026, 8:45 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.00
Real-time Price: $0.7702 info
Change: -$0.2298 (-23%) info
Market Cap: $28.061M info
DYAI
Aug 12, 2026, 8:45 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.00
Real-time Price: $0.7702 info
Change: -$0.2298 (-23%) info
Market Cap: $28.061M info
DYAI
Aug 12, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.00
Real-time Price: $0.7702 info
Change: -$0.2298 (-23%) info
Market Cap: $28.061M info